Aurentz Vincent 4
4 · Inhibikase Therapeutics, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
Aurentz Vincent
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-21+134,427→ 134,427 totalExercise: $2.23Exp: 2035-02-21→ Common Stock (134,427 underlying)
Footnotes (1)
- [F1]The options will vest and become exercisable in two substantially equal installments on the first and second anniversaries of February 21, 2025, subject to the Reporting Person's continued services through such date.